Topspin Fund L.P. 13D/13G Filings for NGM Biopharmaceuticals, Inc. (NGM)

Topspin Fund L.P. 13D and 13G filings for NGM Biopharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-11-20
4:36 pm
Sale
2020-11-2013GNGM Biopharmaceuticals, Inc.
NGM
Topspin Fund L.P.3,320,498
4.800%
-1,512,836decrease
(-31.30%)
Filing